Previous Close | 15.12 |
Open | 15.89 |
Bid | 15.64 x 400 |
Ask | 15.76 x 100 |
Day's Range | 15.48 - 16.12 |
52 Week Range | 13.48 - 39.50 |
Volume | |
Avg. Volume | 648,117 |
Market Cap | 1.584B |
Beta (5Y Monthly) | 1.12 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
As an investor, mistakes are inevitable. But really bad investments should be rare. So take a moment to sympathize with...
Zai Lab Ltd (NASDAQ:ZLAB), a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for cancer, autoimmune, and infectious diseases, has reported an insider sale according to a recent SEC filing.
Zai Lab Limited (NASDAQ:ZLAB) Q4 2023 Earnings Call Transcript February 28, 2024 Zai Lab Limited isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab Full Year 2023 […]